Literature DB >> 21388463

Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.

Benjamin D Young1, Jonathan M Levine, Brian F Porter, Annie V Chen-Allen, John H Rossmeisl, Simon R Platt, Marc Kent, Geoffrey T Fosgate, Scott J Schatzberg.   

Abstract

Astrocytomas and oligodendrogliomas represent one third of histologically confirmed canine brain tumors. Our purpose was to describe the magnetic resonance (MR) imaging features of histologically confirmed canine intracranial astrocytomas and oligodendrogliomas and to examine for MR features that differentiate these tumor types. Thirty animals with confirmed astrocytoma (14) or oligodendroglioma (16) were studied. All oligodendrogliomas and 12 astrocytomas were located in the cerebrum or thalamus, with the remainder of astrocytomas in the cerebellum or caudal brainstem. Most (27/30) tumors were associated with both gray and white matter. The signal characteristics of both tumor types were hypointense on T1-weighted images (12 each) and hyperintense on T2-weighted images (11/14 astrocytomas, 12/16 oligodendrogliomas). For astrocytomas and oligodendrogliomas, respectively, common findings were contrast enhancement (10/13, 11/15), ring-like contrast enhancement (6/10, 9/11), cystic regions within the mass (7/14, 12/16), and hemorrhage (4/14, 6/16). Oligodendrogliomas were significantly more likely to contact the brain surface (meninges) than astrocytomas (14/16, 7/14, respectively, P=0.046). Contact with the lateral ventricle was the most common finding, occurring in 13/14 astrocytomas and 14/16 oligodendrogliomas. No MR features were identified that reliably distinguished between these two tumor types. Contrast enhancement was more common in high-grade tumors (III or IV) than low-grade tumors (II, P=0.008).
© 2010 Veterinary Radiology & Ultrasound.

Entities:  

Mesh:

Year:  2010        PMID: 21388463     DOI: 10.1111/j.1740-8261.2010.01758.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  26 in total

1.  Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Authors:  Hamed Arami; Chirag B Patel; Steven J Madsen; Peter J Dickinson; Ryan M Davis; Yitian Zeng; Beverly K Sturges; Kevin D Woolard; Frezghi G Habte; Demir Akin; Robert Sinclair; Sanjiv S Gambhir
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

2.  Canine intracranial gliomas: relationship between magnetic resonance imaging criteria and tumor type and grade.

Authors:  R T Bentley; C P Ober; K L Anderson; D A Feeney; J F Naughton; J R Ohlfest; M G O'Sullivan; M A Miller; P D Constable; G E Pluhar
Journal:  Vet J       Date:  2013-08-17       Impact factor: 2.688

3.  Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials.

Authors:  Rebecca A Packer; John H Rossmeisl; Michael S Kent; John F Griffin; Christina Mazcko; Amy K LeBlanc
Journal:  Vet Radiol Ultrasound       Date:  2018-03-09       Impact factor: 1.363

4.  Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.

Authors:  A L Bredlau; M A McCrackin; Anjan Motamarry; Kris Helke; Chao Chen; Ann-Marie Broome; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2016

Review 5.  Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

Authors:  Amy K LeBlanc; Christina Mazcko; Diane E Brown; Jennifer W Koehler; Andrew D Miller; C Ryan Miller; R Timothy Bentley; Rebecca A Packer; Matthew Breen; C Elizabeth Boudreau; Jonathan M Levine; R Mark Simpson; Charles Halsey; William Kisseberth; John H Rossmeisl; Peter J Dickinson; Timothy M Fan; Kara Corps; Kenneth Aldape; Vinay Puduvalli; G Elizabeth Pluhar; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2016-05-14       Impact factor: 12.300

6.  Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas.

Authors:  A Courtenay Freeman; Simon R Platt; Shannon Holmes; M Kent; Kelsey Robinson; Elizabeth Howerth; Joe Eagleson; Alexandros Bouras; Milota Kaluzova; Constantinos G Hadjipanayis
Journal:  J Neurooncol       Date:  2018-01-19       Impact factor: 4.130

Review 7.  Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients.

Authors:  John H Rossmeisl; Paulo A Garcia; Gregory B Daniel; John Daniel Bourland; Waldemar Debinski; Nikolaos Dervisis; Shawna Klahn
Journal:  Vet Radiol Ultrasound       Date:  2013-11-13       Impact factor: 1.363

8.  Outcome After Radiation Therapy in Canine Intracranial Meningiomas or Gliomas.

Authors:  TomÁs Rodrigues MagalhÃes; JÉrÔme BenoÎt; SlavomÍra NÉČovÁ; Susan North; Felisbina LuÍsa Queiroga
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 9.  Dogs are man's best friend: in sickness and in health.

Authors:  R Timothy Bentley; Atique U Ahmed; Amy B Yanke; Aaron A Cohen-Gadol; Mahua Dey
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

10.  Clinical features, diagnosis, and survival analysis of dogs with glioma.

Authors:  Roberto José-López; Rodrigo Gutierrez-Quintana; Cristian de la Fuente; Edgar G Manzanilla; Anna Suñol; Dolors Pi Castro; Sonia Añor; Daniel Sánchez-Masian; Francisco Fernández-Flores; Emanuele Ricci; Katia Marioni-Henry; Joan Mascort; Lara A Matiasek; Kaspar Matiasek; Paul M Brennan; Martí Pumarola
Journal:  J Vet Intern Med       Date:  2021-06-12       Impact factor: 3.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.